Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Myocardial Ischemia

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Myocardial Ischemia in 36 studies

Research

Studies (36)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's27 (75.00)18.2507
2000's4 (11.11)29.6817
2010's5 (13.89)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gu, CD; Shi, J; Sun, HT; Tao, YK; Yu, PL; Zhang, GQ; Zhao, SP1
Bessi, VL; Bitencourt, CS; Borgeat, P; Faccioli, LH; Hamdan, L; Huynh, DN; Lefebvre, JS; Lévesque, T; Marleau, S; Ménard, L; Sohouhenou, F1
Alloatti, G; Bassino, E; Penna, C1
Deev, AD; Dobrovol'skiĭ, AB; Katkova, OV; Laguta, PS; Panchenko, EP; Titaeva, EV1
Antonopoulou, S; Chrysohoou, C; Detopoulou, P; Fragopoulou, E; Nomikos, T1
Alloatti, G; Hirsch, E; Lembo, G; Montrucchio, G1
Baker, KE; Curtis, MJ2
Egresits, J; Kordás, K; László, F; László, FA; Morschl, E; Nemcsik, J; Pávó, I1
Chin, TK; Hofmann, PA; Leary, PJ; Morrison, RR; Rajasekaran, S; Tuomanen, EI1
Altavilla, D; Bussolino, F; Campo, GM; Canale, P; Caputi, AP; Ioculano, M; Sardella, A; Squadrito, F; Urna, G1
Barrigón, S; Fernandez-Gallardo, S; Fernandez-Sanpablo, R; Perez, MD; Salinas, P; Sanchez-Crespo, M1
Becker, BF; Raschke, P1
Flores, NA; Goulielmos, NV; Seghatchian, MJ; Sheridan, DJ1
Filep, JG; Földes-Filep, E; Fournier, A1
Inada, M; Iwasaka, T; Izuoka, T; Kimura, Y; Kitashiro, S; Tamura, K; Tamura, T1
Braquet, PG; Guinot, P; Hosford, D; Koltai, M1
Danchak, RM; Heim, KF; Kim, YD; Lees, DE; Myers, AK1
Altavilla, D; Bussolino, F; Calapai, G; Campo, GM; Canale, P; Caputi, AP; Ioculano, M; Saitta, A; Squadrito, F; Zingarelli, B1
Chen, BN; McLennan, PL; Menadue, MF; Oliver, JR; Rayner, TE1
Baudouy, M; Blanc, P; Ferrari, E; Jambou, D; Morand, P1
Alloatti, G; Cacace, G; Camussi, G; Comino, A; De Filippi, PG; Emanuelli, G; Mariano, F; Montrucchio, G; Polloni, R1
Hackett, D; O'Gorman, DJ; Shahi, M; Sheridan, DJ; Siminiak, T1
Azizova, OA; Fortinskaia, ES; Khalilov, EM; Torkhovskaia, TI; Vlasova, II1
Feuerstein, G; Leor, J; Rabinovici, R; Vonhof, S; Winkler, JD1
Ansley, DM; English, JC; Godin, DV; Kim, CW; Lee, JU; Loucks, EB; Qayumi, AK1
Bache, RJ; Kinn, JW1
Auchampach, JA; Cavero, I; Gross, GJ; Pieper, GM1
Gerritsen, ME; Granger, DN; Horie, Y; Mori, N1
Ambrosio, G; Tritto, I1
Porsius, AJ; Vleeming, W; Wemer, J1
Black, SC; Driscoll, EM; Lucchesi, BR1
Ankri, A; Drobinski, G; Grosgogeat, Y; Maclouf, J; Mencia-Huerta, JM; Montalescot, G; Thomas, D1
Chakrabarty, S; Flores, NA; Fluck, DS; Sheridan, DJ1
Schoonderwoerd, K; Stam, H1
Wysocki, H1

Reviews

8 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Myocardial Ischemia

ArticleYear
Platelet activating factor: the good and the bad in the ischemic/reperfused heart.
    Experimental biology and medicine (Maywood, N.J.), 2011, Apr-01, Volume: 236, Issue:4

    Topics: Humans; Ischemic Preconditioning; Myocardial Ischemia; Myocardial Reperfusion Injury; Platelet Activating Factor

2011
Platelet activating factor in heart failure: potential role in disease progression and novel target for therapy.
    Current heart failure reports, 2013, Volume: 10, Issue:2

    Topics: Animals; Atherosclerosis; Cardiotonic Agents; Disease Progression; Drug Design; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Myocardial Ischemia; Platelet Activating Factor

2013
Phosphoinositide 3-kinase gamma: kinase-dependent and -independent activities in cardiovascular function and disease.
    Biochemical Society transactions, 2004, Volume: 32, Issue:Pt 2

    Topics: Animals; Cardiovascular System; Class Ib Phosphatidylinositol 3-Kinase; Cyclic AMP; Disease Models, Animal; Heart Diseases; Humans; Isoenzymes; Mice; Mice, Transgenic; Myocardial Ischemia; Nitric Oxide; Phenotype; Phosphatidylinositol 3-Kinases; Platelet Activating Factor; Receptors, G-Protein-Coupled; Signal Transduction

2004
Platelet-activating factor antagonists: scientific background and possible clinical applications.
    Advances in pharmacology (San Diego, Calif.), 1994, Volume: 28

    Topics: Animals; Antibodies, Monoclonal; Brain Ischemia; Bronchoconstriction; Humans; Inflammation; Lipopolysaccharides; Myocardial Ischemia; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Shock, Septic

1994
Platelet-activating factor and cardiac diseases: therapeutic potential for PAF inhibitors.
    Journal of lipid mediators and cell signalling, 1997, Volume: 15, Issue:3

    Topics: Animals; Cells, Cultured; Coronary Vessels; Heart; Heart Diseases; Heart Transplantation; Humans; Molecular Structure; Myocardial Contraction; Myocardial Ischemia; Myocardium; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled

1997
Reperfusion injury: experimental evidence and clinical implications.
    American heart journal, 1999, Volume: 138, Issue:2 Pt 2

    Topics: Capillaries; Cell Adhesion Molecules; Coronary Circulation; Coronary Vessels; Free Radicals; Heart; Humans; Inflammation Mediators; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardial Stunning; Myocardium; Neutrophil Activation; Neutrophils; Nitric Oxide; Oxidative Stress; Platelet Activating Factor; Reactive Oxygen Species; Thromboplastin

1999
Lipid metabolism of myocardial endothelial cells.
    Molecular and cellular biochemistry, 1992, Oct-21, Volume: 116, Issue:1-2

    Topics: Animals; Biological Transport; Cholesterol; Eicosanoids; Endocardium; Humans; Lipid Metabolism; Lipolysis; Lipoproteins; Membrane Lipids; Myocardial Ischemia; Myocardial Reperfusion Injury; Oxidation-Reduction; Phospholipids; Platelet Activating Factor; Triglycerides

1992
The role of polymorphonuclear neutrophils in myocardial damage during ischemia and reperfusion.
    Archivum immunologiae et therapiae experimentalis, 1992, Volume: 40, Issue:1

    Topics: Animals; Antioxidants; Capillary Resistance; Cell Adhesion; Endopeptidases; Endothelium, Vascular; Free Radicals; Humans; Hypoxanthine; Hypoxanthines; Leukotrienes; Myocardial Ischemia; Myocardial Reperfusion Injury; Neutrophils; Oxygen; Platelet Activating Factor; Platelet Aggregation; Respiratory Burst

1992

Trials

1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Myocardial Ischemia

ArticleYear
[Aspirin resistance in patients with stable ischemic heart disease].
    Kardiologiia, 2010, Volume: 50, Issue:11

    Topics: Aged; Aspirin; Coronary Angiography; Drug Monitoring; Drug Resistance; Echocardiography, Transesophageal; Electrocardiography; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Activating Factor; Risk Factors; Severity of Illness Index; Thromboxane B2; Treatment Outcome

2010

Other Studies

27 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Myocardial Ischemia

ArticleYear
Elevated platelet activating factor level in ischemia-related arrhythmia and its electrophysiological effect on myocardium.
    Biomedical and environmental sciences : BES, 2013, Volume: 26, Issue:5

    Topics: Animals; Arrhythmias, Cardiac; Electrocardiography; Female; Heart; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Activating Factor; Swine

2013
Cooperative role of endogenous leucotrienes and platelet-activating factor in ischaemia-reperfusion-mediated tissue injury.
    Journal of cellular and molecular medicine, 2013, Volume: 17, Issue:12

    Topics: Amidines; Animals; Azepines; Biological Assay; Carbamates; Dermis; Disease Models, Animal; Extravasation of Diagnostic and Therapeutic Materials; Extremities; Inflammation; Leukotriene B4; Leukotrienes; Male; Mice; Mice, Inbred C57BL; Myocardial Ischemia; Neutrophil Infiltration; Platelet Activating Factor; Platelet Membrane Glycoproteins; Propionates; Quinolines; Rabbits; Receptors, G-Protein-Coupled; Receptors, Leukotriene; Reperfusion Injury; Triazoles

2013
Left regional cardiac perfusion in vitro with platelet-activating factor, norepinephrine and K+ reveals that ischaemic arrhythmias are caused by independent effects of endogenous "mediators" facilitated by interactions, and moderated by paradoxical antago
    British journal of pharmacology, 2004, Volume: 142, Issue:2

    Topics: Animals; Azepines; Coronary Vessels; Heart Ventricles; In Vitro Techniques; Male; Myocardial Ischemia; Norepinephrine; Perfusion; Platelet Activating Factor; Potassium; Rats; Rats, Wistar; Triazoles; Ventricular Fibrillation; Ventricular Function

2004
Synergistic interaction of endogenous platelet-activating factor and vasopressin in generating angina in rats.
    European journal of pharmacology, 2004, Sep-13, Volume: 498, Issue:1-3

    Topics: Angina Pectoris; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Diterpenes; Dose-Response Relationship, Drug; Drug Interactions; Electrocardiography; Epinephrine; Ginkgolides; Heart Rate; Hormone Antagonists; Injections, Intravenous; Lactones; Male; Myocardial Ischemia; Ornipressin; Phentolamine; Platelet Activating Factor; Rats; Rats, Wistar; Receptors, Vasopressin; Time Factors; Vasoconstrictor Agents; Vasopressins

2004
A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.
    American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:6

    Topics: Animals; Calcium; Calcium Signaling; Cell Shape; Cyclic GMP; Disease Models, Animal; Enzyme Inhibitors; Female; Ginkgolides; Lactones; Male; Mice; Mice, Inbred C57BL; Muscle Proteins; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Platelet Activating Factor; Rats; Rats, Wistar; Time Factors; Ventricular Function, Left

2008
Protective effects of L-659,989, a platelet-activating factor receptor antagonist, in myocardial ischemia and reperfusion in rats.
    Journal of cardiovascular pharmacology, 1994, Volume: 23, Issue:1

    Topics: Animals; Creatine Kinase; Disease Models, Animal; Furans; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Peroxidase; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Survival Rate

1994
Lack of platelet-activating factor release on acute myocardial ischemia in the isolated interventricular septum of rabbit heart.
    European journal of pharmacology, 1995, May-26, Volume: 293, Issue:1

    Topics: Acute Disease; Animals; Chromatography, High Pressure Liquid; Diterpenes; Fibrinolytic Agents; Ginkgolides; Heart Ventricles; In Vitro Techniques; Lactones; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Platelet Activating Factor; Rabbits

1995
Adenosine and PAF dependent mechanisms lead to myocardial reperfusion injury by neutrophils after brief ischaemia.
    Cardiovascular research, 1995, Volume: 29, Issue:4

    Topics: Adenosine; Animals; Azepines; Guinea Pigs; Heart; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Neutrophil Activation; Neutrophils; Perfusion; Platelet Activating Factor; Receptors, Purinergic P1; Theobromine; Triazoles; Xanthines

1995
Myocardial ischaemia induces platelet activation with adverse electrophysiological and arrhythmogenic effects.
    Cardiovascular research, 1994, Volume: 28, Issue:11

    Topics: Animals; Arrhythmias, Cardiac; Aspirin; Biphenyl Compounds; Blood Platelets; Colforsin; Diterpenes; Electrophysiology; Ginkgolides; Guinea Pigs; Heart; Heptanoic Acids; Lactones; Male; Myocardial Ischemia; Oxidopamine; Platelet Activating Factor; Platelet Activation; Platelet Aggregation Inhibitors; Receptors, Thromboxane; Yohimbine

1994
Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2.
    British journal of pharmacology, 1994, Volume: 112, Issue:3

    Topics: Anesthesia; Animals; Blood Pressure; Capillary Permeability; Edema; Electrocardiography; Endothelin Receptor Antagonists; Endothelins; Heart Rate; In Vitro Techniques; Male; Myocardial Ischemia; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, Endothelin; Receptors, G-Protein-Coupled; Receptors, Thromboxane; Thromboxane A2

1994
The effects of platelet activating factor antagonist, TCV309, on the relationship between electrophysiological and mechanical status during myocardial ischemia and reperfusion.
    Annals of the New York Academy of Sciences, 1994, Jun-17, Volume: 723

    Topics: Action Potentials; Animals; Dogs; Electrophysiology; Hemodynamics; Isoquinolines; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Platelet Activating Factor; Pyridinium Compounds; Tetrahydroisoquinolines

1994
Constriction of canine coronary arteries by platelet activating factor after brief ischemia.
    Prostaglandins, 1993, Volume: 46, Issue:3

    Topics: Acetylcholine; Animals; Blood Pressure; Coronary Circulation; Coronary Vessels; Dogs; Female; Heart Rate; Hemodynamics; Male; Muscle, Smooth, Vascular; Myocardial Ischemia; Platelet Activating Factor; Regional Blood Flow; Reperfusion; Time Factors; Vascular Resistance; Vasoconstriction; Vasodilation

1993
Platelet activating factor interaction with tumor necrosis factor in myocardial ischaemia-reperfusion injury.
    Journal of lipid mediators, 1993, Volume: 8, Issue:1

    Topics: Analysis of Variance; Animals; Biological Assay; Creatine Kinase; Isoenzymes; Leukopenia; Macrophages; Male; Myocardial Ischemia; Myocardial Reperfusion; Necrosis; Peroxidase; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tumor Necrosis Factor-alpha

1993
Effect of ischaemia and role of eicosanoids in release of atrial natriuretic factor from rat heart.
    Cardiovascular research, 1993, Volume: 27, Issue:9

    Topics: Animals; Atrial Natriuretic Factor; Disease Models, Animal; Diterpenes; Eicosanoids; Ginkgolides; Heart Rate; Lactones; Male; Masoprocol; Meclofenamic Acid; Myocardial Contraction; Myocardial Ischemia; Myocardium; Perfusion; Platelet Activating Factor; Rats; Rats, Inbred Strains; Secretory Rate

1993
[Mediators of the vascular endothelium as markers of myocardial ischemia and reperfusion].
    Archives des maladies du coeur et des vaisseaux, 1993, Volume: 86 Spec No 4

    Topics: Endothelins; Endothelium, Vascular; Epoprostenol; Humans; Myocardial Ischemia; Myocardial Reperfusion; Nitric Oxide; Platelet Activating Factor

1993
Role of platelet-activating factor in polymorphonuclear neutrophil recruitment in reperfused ischemic rabbit heart.
    The American journal of pathology, 1993, Volume: 142, Issue:2

    Topics: Animals; Azepines; Cell Movement; Female; Heart; Hemodynamics; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Platelet Activating Factor; Quinolines; Rabbits; Risk Factors; Triazoles

1993
Plasma mediated neutrophil stimulation during coronary angioplasty: autocrine effect of platelet activating factor.
    British heart journal, 1995, Volume: 74, Issue:6

    Topics: Angioplasty, Balloon, Coronary; Azepines; CD18 Antigens; Cells, Cultured; Coronary Circulation; Diterpenes; Femoral Artery; Femoral Vein; Ginkgolides; Humans; Lactones; Myocardial Ischemia; Neutrophil Activation; Neutrophils; Platelet Activating Factor; Superoxides; Triazoles

1995
[Effect of a micellar preparation of polyunsaturated phosphatidylcholine on platelet aggregation in vitro].
    Biulleten' eksperimental'noi biologii i meditsiny, 1996, Volume: 121, Issue:2

    Topics: Adenosine Diphosphate; Fatty Acids, Unsaturated; Humans; Micelles; Myocardial Ischemia; Phosphatidylcholines; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors

1996
The role of platelet-activating factor in regional myocardial ischemia-reperfusion injury.
    The Annals of thoracic surgery, 1998, Volume: 65, Issue:6

    Topics: Animals; Arrhythmias, Cardiac; Atrial Fibrillation; Blood Pressure; Cardiac Output; Cardiac Volume; Disease Models, Animal; Female; Heart Arrest; Hemodynamics; Isoquinolines; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Neutrophils; Platelet Activating Factor; Platelet Aggregation Inhibitors; Pyridinium Compounds; Random Allocation; Stroke Volume; Swine; Tetrahydroisoquinolines; Ventricular Fibrillation; Ventricular Function

1998
Effect of platelet activation on coronary collateral blood flow.
    Circulation, 1998, Oct-06, Volume: 98, Issue:14

    Topics: Animals; Blood Platelets; Collateral Circulation; Coronary Circulation; Dogs; Myocardial Ischemia; Platelet Activating Factor; Platelet Activation; Thromboxane A2; Vasoconstriction

1998
Effect of the platelet-activating factor antagonist RP 59227 (Tulopafant) on myocardial ischemia/reperfusion injury and neutrophil function.
    Basic research in cardiology, 1998, Volume: 93, Issue:5

    Topics: Animals; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Female; Free Radicals; Incidence; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Neutrophils; Peroxidase; Platelet Activating Factor; Pyridines; Reperfusion Injury; Thiazoles; Ventricular Fibrillation

1998
Ischemia-reperfusion induced microvascular responses in LDL-receptor -/- mice.
    The American journal of physiology, 1999, Volume: 276, Issue:5

    Topics: Animals; Antibodies, Monoclonal; Arteriosclerosis; Cell Adhesion; Hypercholesterolemia; Intercellular Adhesion Molecule-1; Leukocytes; Leukotrienes; Male; Mice; Mice, Knockout; Microcirculation; Myocardial Ischemia; Myocardial Reperfusion Injury; Platelet Activating Factor; Receptors, LDL; Serum Albumin

1999
Protection against ventricular fibrillation by the PAF antagonist, BN-50739, involves an ischaemia-selective mechanism.
    Journal of cardiovascular pharmacology, 1999, Volume: 34, Issue:3

    Topics: Animals; Anti-Arrhythmia Agents; Azepines; Disease Models, Animal; Male; Myocardial Ischemia; Perfusion; Platelet Activating Factor; Protective Agents; Rats; Rats, Wistar; Triazoles; Vasodilation; Ventricular Fibrillation

1999
Modulation of antigen- and ischemia-induced effects by the platelet-activating factor antagonist WEB-2086 in isolated sensitized rat hearts.
    Journal of cardiovascular pharmacology, 1992, Volume: 20, Issue:5

    Topics: Anaphylaxis; Animals; Antigens; Azepines; Chromatography, High Pressure Liquid; Chromones; Coronary Circulation; Heart; Histamine Release; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion; Platelet Activating Factor; Pressure; Rats; Rats, Wistar; Triazoles

1992
Inhibition of platelet-activating factor fails to limit ischemia and reperfusion-induced myocardial damage.
    Journal of cardiovascular pharmacology, 1992, Volume: 20, Issue:6

    Topics: Animals; Azepines; Blood Pressure; Coronary Circulation; Dogs; Heart Rate; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Platelet Activating Factor; Platelet Aggregation; Triazoles

1992
Lack of platelet-activating factor release during reversible myocardial ischaemia.
    European heart journal, 1992, Volume: 13, Issue:12

    Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Humans; Myocardial Ischemia; Platelet Activating Factor; Thromboxane B2

1992
Effects of the PAF antagonists BN50726 and BN50739 on arrhythmogenesis and extent of necrosis during myocardial ischaemia/reperfusion in rabbits.
    British journal of pharmacology, 1992, Volume: 107, Issue:3

    Topics: Animals; Arrhythmias, Cardiac; Azepines; Blood Pressure; Electrocardiography; Heart Rate; Hemodynamics; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Necrosis; Platelet Activating Factor; Rabbits; Thienopyridines; Triazoles

1992